| Cat. No. |
Size |
Price |
Figures |
RP13668-0.2 mg
| 0.2 mg | $ 104.50 | MSDS: 20080911212403 (PDF) STRUCTURE:
 Zoom
References:
- Hamakubo T, Yoshida M et al. Central cardiovascular effects of joining peptide in genetically hypertensive rats. Am J Physiol. Nov 1993;265(5 Pt 2):R1184-90.
- Cullen EI, Mains RE et al. Biosynthesis of amidated joining peptide from pro-adrenocorticotropin-endorphin. Mol Endocrinol. Sep 1987;1(9):583-94.
|
|---|
| Full Name | |
Sequence (one-letter code) |
AEEETAGGDGRPEPSPRE-NH2 |
Sequence (three-letter code) | {ALA}{GLU}{GLU}{GLU}{THR}{ALA}{GLY}{GLY}{ASP}{GLY} {ARG}{PRO}{GLU}{PRO}{SER}{PRO}{ARG}{GLU}-NH2 |
| C-Terminal | NH2 |
|---|
| Description | Joining peptide is the major alpha-amidated product of pro-ACTH/endorphin (PAE) in AtT-20 corticotropic tumor cells. JP, which was isolated from bovine posterior pituitary, possesses Na pump inhibitor activity. |
|---|
| Solubility | Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents. |
|---|
| Formula | C75H119N25O32 |
| M.W. | 1882.9 |
| Purity | > 95% |
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| Notes | Pivotal neuropeptide in cardiovascular regulation. |